1 Brenner H, Kloor M, Pox CP. Colorectal cancer. Lancet. 2014;383(9927):1490–502.
2 Terzic J, Grivennikov S, Karin E, Karin M. Inflammation and colon cancer. Gastroenterology. 2010;138:2101–14 e2105.
3 McMillan DC, Canna K, McArdle CS. Systemic inflammatory response predicts survival following curative resection of colorectal
cancer. Br J Surg. 2003;90(2):215–9.
4 Tanaka H, Muguruma K, Toyokawa T, Kubo
N, Ohira M, Hirakawa K. Differential impact
of the neutrophil-lymphocyte ratio on the
survival of patients with stage IV gastric cancer. Dig Surg. 2014;31(4–5):327–33.
5 Kanda M, Fujii T, Kodera Y, Nagai S, Takeda
S, Nakao A. Nutritional predictors of postoperative outcome in pancreatic cancer. Br J
Surg. 2011;98(2):268–74.
6 Proctor MJ, Morrison DS, Talwar D, Balmer
SM, Fletcher CD, O'Reilly DS, et al. A comparison of inflammation-based prognostic
scores in patients with cancer. A glasgow inflammation outcome study. Eur J Cancer.
2011;47(17):2633–41.
7 Assicot M, Gendrel D, Carsin H, Raymond J,
Guilbaud J, Bohuon C. High serum procalcitonin concentrations in patients with sepsis
and infection. Lancet. 1993;341(8844):515–8.
8 Iida H, Maehira H, Mori H, Tani M. Serum
procalcitonin as a predictor of infectious
complications after pancreaticoduodenectomy: review of the literature and our experience. Surg Today. 2020 Feb;50(2):87–96.
9 Shimizu T, Obata T, Sonoda H, Akabori H, Miyake T, Yamamoto H, et al. Diagnostic potential of endotoxin scattering photometry for sepsis and septic shock. Shock. 2013;40(6):504–11.
10 Cotoi OS, Manjer J, Hedblad B, Engström G,
Melander O, Schiopu A. Plasma procalcito-
PCT and Prognosis for Colorectal Cancer
nin is associated with all-cause and cancer
mortality in apparently healthy men: a prospective population-based study. BMC Med.
2013;11:180.
11 Shimizu T, Hanasawa K, Sato K, Umeki M,
Koga N, Naganuma T, et al. Perforation
PMXTSGiSPwC: the clinical significance of
serum procalcitonin levels following direct
hemoperfusion with polymyxin B-immobilized fiber column in septic patients with
colorectal perforation. Eur Surg Res. 2009;42:
109–17.
12 Horan TC, Andrus M, Dudeck MA. CDC/
NHSN surveillance definition of health careassociated infection and criteria for specific
types of infections in the acute care setting.
Am J Infect Control. 2008;36(5):309–32.
13 Rhodes A, Evans LE, Alhazzani W, Levy MM,
Antonelli M, Ferrer R, et al. Surviving sepsis
campaign: international guidelines for management of sepsis and septic shock: 2016. Intensive Care Med. 2017;43(3):304–77.
14 Reith HB, Mittelkötter U, Debus ES, Küssner
C, Thiede A. Procalcitonin in early detection
of postoperative complications. Dig Surg.
1998;15(3):260–5.
15 Matzaraki V, Alexandraki KI, Venetsanou K,
Piperi C, Myrianthefs P, Malamos N, et al.
Evaluation of serum procalcitonin and interleukin-6 levels as markers of liver metastasis.
Clin Biochem. 2007;40(5–6):336–42.
16 Shen H, Zheng S, Chen R, Jin X, Xu X, Jing C,
et al. Prognostic significance of serum procalcitonin in patients with unresectable hepatocellular carcinoma treated with transcatheter arterial chemoembolization: a retrospective analysis of 509 cases. Medicine. 2017;96(28):e7438.
17 Chen L, Zhang Y, Lin Y, Deng L, Feng S, Chen
M, et al. The role of elevated serum procalci-
Dig Surg
DOI: 10.1159/000511908
tonin in neuroendocrine neoplasms of digestive system. Clin Biochem. 2017;50:982–7.
18 Patout M, Salaün M, Brunel V, Bota S, Cauliez
B, Thiberville L. Diagnostic and prognostic
value of serum procalcitonin concentrations
in primary lung cancers. Clin Biochem. 2014;
47(18):263–7.
19 Sugimoto K, Komiyama H, Kojima Y, Goto
M, Tomiki Y, Sakamoto K. Glasgow prognostic score as a prognostic factor in patients undergoing curative surgery for colorectal cancer. Dig Surg. 2012;29(6):503–9.
20 Carroll GM, Burns GL, Petit JA, Walker MM,
Mathe A, Smith SR, et al. Does postoperative
inflammation or sepsis generate neutrophil
extracellular traps that influence colorectal
cancer progression? A systematic review.
Surg Open Sci. 2020;2(2):57–69.
21 Liu J, Lin PC, Zhou BP. Inflammation fuels
tumor progress and metastasis. Curr Pharm
Des. 2015;21(21):3032–40.
22 Oberhoffer M, Stonans I, Russwurm S,
Stonane E, Vogelsang H, Junker U, et al. Procalcitonin expression in human peripheral
blood mononuclear cells and its modulation
by lipopolysaccharides and sepsis-related cytokines in vitro. J Lab Clin Med. 1999;134(1):
49–55.
23 Liu X, Cheng Y, Shao L, Ling Z. Alterations of
the predominant fecal microbiota and disruption of the gut mucosal barrier in patients
with early-stage colorectal cancer. Biomed
Res Int. 2020;2020:2948282.
24 Messaritakis I, Vogiatzoglou K, Tsantaki K,
Ntretaki A, Sfakianaki M, Koulouridi A, et
al. The prognostic value of the detection of
microbial translocation in the blood of
colorectal cancer patients. Cancers. 2020;
12(4): 1058.
...
論文の公開元へ
